Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BRAF V600E mutation and the tumour suppressor IGFBP7 in atypical genital naevi.

The British journal of dermatology - 1 Mar 2010

Nguyen L P, Emley A, Wajapeyee N, Green M R, Mahalingam M

Abstract excerpt

BACKGROUND: Atypical genital naevi (AGN) are naevi of special sites with atypical histological features that overlap with those of malignant melanoma. Activating BRAF mutations, identified in the majority of banal melanocytic naevi and cutaneous melanomas, are reportedly uncommon in naevomelanocy...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Dysplastic Nevus Syndrome
Share to Genes, Tumor Suppressor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Insulin-Like Growth Factor Binding Proteins

Share to Mutation

Share to Proto-Oncogene Proteins B-raf

Share to Tumor Suppressor Proteins

Share to Young Adult

Source

Open in PubMed Open full text

Identifiers

PMID: 19919630
DOI: 10.1111/j.1365-2133.2009.09558.x
PMCID: PMC2921125

Genes

BRAF
IGFBP7

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19919630-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BRAF V600E mutation and the tumour suppressor IGFBP7 in atypical genital naevi.PMID 19919630Read ↗

Oncogenic BRAF-positive dysplastic nevi and the tumor suppressor IGFBP7--challenging the concept of dysplastic nevi as precursor lesions?Semantic proximity Read ↗

The BRAF and NRAS mutation prevalence in dermoscopic subtypes of acquired naevi reveals constitutive mitogen-activated protein kinase pathway activation.Semantic proximity Read ↗

The clinico‐pathological spectrum of plaque‐type blue naevi and their potential for malignant transformationSemantic proximity Read ↗

Melanocytic naevi with globular and reticular dermoscopic patterns display distinct BRAF V600E expression profiles and histopathological patterns.Semantic proximity Read ↗

Decoding the Molecular Mechanisms of BRAF V600E-Induced Nevi Formation.Semantic proximity Read ↗

Naevus sebaceus: a mosaic RASopathy.Semantic proximity Read ↗

Oncogenic BRAF and the tumor suppressor IGFBP7 in the genesis of atypical spitzoid nevomelanocytic proliferations.Semantic proximity Read ↗

Human acquired naevi are clonalSemantic proximity Read ↗

The role of atypical mole syndrome and cutaneous naevi in the development of melanoma.Semantic proximity Read ↗

Activating BRAF mutations in eruptive melanocytic naevi.Semantic proximity Read ↗

Congenital melanocytic nevi frequently harbor NRAS mutations but no BRAF mutations.Semantic proximity Read ↗

The association of BRAF V600E gene mutation with proliferative activity and histopathological characteristics of congenital melanocytic nevi in children.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.